140 related articles for article (PubMed ID: 9262576)
21. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis.
Passlick B; Izbicki JR; Kubuschok B; Thetter O; Pantel K
Ann Thorac Surg; 1996 Jan; 61(1):177-82; discussion 183. PubMed ID: 8561549
[TBL] [Abstract][Full Text] [Related]
22. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
24. Micrometastases in bone marrow of patients with suspected pancreatic and ampullary cancer.
van Heek NT; Tascilar M; van Beekveld JL; Drillenburg P; Offerhaus GJ; Gouma DJ
Eur J Surg Oncol; 2001 Dec; 27(8):740-5. PubMed ID: 11735170
[TBL] [Abstract][Full Text] [Related]
25. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases.
Choesmel V; Anract P; Høifødt H; Thiery JP; Blin N
Cancer; 2004 Aug; 101(4):693-703. PubMed ID: 15305398
[TBL] [Abstract][Full Text] [Related]
26. [Simultaneous immunocytochemical detection of tumor cells in lymph nodes and in bone marrow of patients with resectable bronchial carcinomas].
Passlick B; Pantel K; Kubuschok B; Izbicki JR; Thetter O
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):21-4. PubMed ID: 14518204
[TBL] [Abstract][Full Text] [Related]
27. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer.
Ito M; Minamiya Y; Kawai H; Saito S; Saito H; Imai K; Ogawa J
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):753-8. PubMed ID: 16153924
[TBL] [Abstract][Full Text] [Related]
28. Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer.
Maehara Y; Hasuda S; Abe T; Oki E; Kakeji Y; Ohno S; Sugimachi K
Clin Cancer Res; 1998 Sep; 4(9):2129-34. PubMed ID: 9748130
[TBL] [Abstract][Full Text] [Related]
29. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
Soria JC; Jang SJ; Khuri FR; Hassan K; Liu D; Hong WK; Mao L
Cancer Res; 2000 Aug; 60(15):4000-4. PubMed ID: 10945597
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
Wang Y; Zhang XR; Fu J; Tan W; Zhang W
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
[TBL] [Abstract][Full Text] [Related]
32. Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.
Kakolyris S; Giatromanolaki A; Koukourakis M; Powis G; Souglakos J; Sivridis E; Georgoulias V; Gatter KC; Harris AL
Clin Cancer Res; 2001 Oct; 7(10):3087-91. PubMed ID: 11595699
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of cytokeratin-positive cells in the bone marrows of colorectal carcinoma patients.
Shetye JD; Liljefors ML; Emdin SO; Frödin JE; Strigård K; Mellstedt HT; Porwit A
Anticancer Res; 2004; 24(4):2375-83. PubMed ID: 15330187
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
Hsu NY; Ho HC; Chow KC; Lin TY; Shih CS; Wang LS; Tsai CM
Cancer Res; 2001 Mar; 61(6):2727-31. PubMed ID: 11289154
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow involvement in esophageal cancer patients who underwent surgical resection.
Bagheri R; Maddah G; Saedi HS; Sadeghian MH; Roodbari S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):343-6. PubMed ID: 21345693
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic value of P53 protein in cells of non-small cell lung cancer].
Jassem E; Góźdź S; Badzio A; Kobierska G; Skokowski J; Damps I; Urbaniak A; Jassem J
Pneumonol Alergol Pol; 2000; 68(7-8):327-35. PubMed ID: 11200747
[TBL] [Abstract][Full Text] [Related]
38. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.
Dobashi K; Sugio K; Osaki T; Oka T; Yasumoto K
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):339-46. PubMed ID: 9305185
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer.
Osaki T; Oyama T; Gu CD; Yamashita T; So T; Takenoyama M; Sugio K; Yasumoto K
J Clin Oncol; 2002 Jul; 20(13):2930-6. PubMed ID: 12089221
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer: flow cytometric methods for detection of bone marrow micrometastases.
Hussain M; Kukuruga M; Biggar S; Sakr W; Cummings G; Ensley J
Cytometry; 1996 Mar; 26(1):40-6. PubMed ID: 8809479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]